Manufacturer:
Misc
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- managing secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15-55 mL/min)
- managing hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis
- managing hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism
Conditions:
- Hypocalcemia
- Secondary Hyperparathyroidism
Therapeutic Area:
- Oncology